Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Tuberculosis Patients
60%
Indonesia
56%
Pulmonary Tuberculosis
44%
Pulmonary Patients
42%
Multidrug-resistant Tuberculosis (MDR-TB)
36%
Surabaya Indonesia
36%
Drug-resistant Tuberculosis (DR-TB)
34%
Bedaquiline
33%
COVID-19
24%
Antibacterial Activity
21%
Surabaya
20%
Rifampicin
19%
Sputum
18%
Rifampicin-resistant Tuberculosis (RR-TB)
18%
Risk Factors
15%
Escherichia Coli
15%
Indonesian
15%
Diabetes Mellitus
15%
Tuberculosis Treatment
14%
TB Patients
14%
Xpert MTB/RIF Assay
14%
Short-term Treatment
14%
Passiflora Edulis
12%
Tertiary Referral Hospital
12%
West Java Indonesia
12%
Referral Hospital
11%
Rifampicin Resistance
11%
General Hospital
11%
QTc Interval
10%
Medical Records
10%
Tuberculosis Diagnosis
10%
Delamanid
10%
Population Pharmacokinetics (PopPK)
10%
QTc Prolongation
10%
Moxifloxacin
9%
Culture Method
9%
Staphylococcus
9%
Antibiotics
8%
Active Tuberculosis
8%
GeneXpert
8%
Chest X-ray
8%
Xpert
8%
Intensive Phase
8%
Antimicrobial Activity
7%
C-reactive Protein
7%
Lung Tuberculosis
7%
Household Contacts
7%
Red Passion Fruit
7%
Treatment Outcome
7%
Acid-fast Bacilli
7%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
7%
Minimum Inhibitory Concentration
7%
Sputum Samples
7%
Clinical Outcomes
7%
N-acetyltransferase 2 (NAT2)
6%
Whole Genome Sequencing
6%
Linezolid
6%
Meta-analysis
6%
Academic Hospital
6%
Anti-tuberculosis Drugs
6%
Lung Damage
6%
16S Ribosomal RNA (16S rRNA)
6%
MGIT 960
6%
Latent Tuberculosis Infection
6%
Sputum Conversion
5%
Inhibitory Activity
5%
Exclusion Criteria
5%
East Java
5%
Microscopy
5%
Indonesian Patients
5%
Loss-to-follow-up
5%
Comorbidity
5%
Pyrazinamide
5%
Multidrug-resistant
5%
Tuberculous Lymphadenitis
5%
Lactic Acid Bacteria
5%
Methicillin-resistant Staphylococcus Aureus
5%
Treatment Failure
5%
Ag85B
5%
Tertiary Care Centers
5%
Drug Sensitivity
5%
Mycobacterium
5%
Polymerase Chain Reaction
5%
Childhood Tuberculosis
5%
Pneumonia Patients
5%
Peripheral Blood Mononuclear Cells
5%
Inflammatory Cytokines
5%
Fine-needle Aspiration Biopsy
5%
Multidrug-resistant Organisms
5%
Drug Exposure
5%
Streptomyces Sp
5%
Chronic Obstructive Pulmonary Disease
5%
Potential Biomarkers
5%
Saccharum Officinarum
5%
Lung Tissue Damage
5%
Cell-free
5%
Aqueous Extract
5%
Jember
5%
Cloning Expression
5%
Medicine and Dentistry
Tuberculosis
55%
Drug Resistant Tuberculosis
46%
Lung Tuberculosis
38%
Mycobacterium Tuberculosis
34%
Multidrug Resistant Tuberculosis
29%
Rifampicin
29%
Bedaquiline
27%
Sputum
20%
Patient Referral
16%
QTc Interval
16%
COVID-19
12%
Diabetes Mellitus
11%
Diseases
11%
Delamanid
10%
Moxifloxacin
9%
Treatment Outcome
8%
Culture Conversion
8%
Atypical Mycobacterium
8%
Systematic Review
7%
Cross Sectional Study
7%
Single Nucleotide Polymorphism
7%
Medical Record
7%
Infection
6%
Sputum Culture
6%
Linezolid
6%
Extrapulmonary Tuberculosis
6%
Potassium
5%
Side Effect
5%
Human Immunodeficiency Virus
5%
Chest Radiograph
5%
Cohort Analysis
5%
Comorbidity
5%
C Reactive Protein
5%
Adenosine Deaminase
5%
Tuberculous Lymphadenitis
5%
Inflammatory Cytokine
5%
Quinolone Derivative
5%
Genetics
5%
Tuberculosis Treatment
5%